Alesi Surgical, a leading innovator of advanced minimally invasive surgery technologies, based at Cardiff Medicentre and Adachi Co., Ltd. today announce regulatory approval of the Ultravision™ visual field clearing system by the Japanese Ministry of Health, Labour and Welfare and an exclusive agreement in Japan.
Adachi Co., Ltd. was founded as a family-owned medical and scientific products distributor in 1931. It has since grown into a leading distributor of innovative medical devices with sales, marketing and services capabilities throughout Japan. Adachi has successfully established relationships with leading hospitals and medical organizations across the country and has deep expertise in the field of laparoscopic surgery gained through previous and current distribution of products for leading companies such as Olympus and Intuitive Surgical.
Under the terms of the agreement, which were not disclosed, Adachi will be responsible for the sales, marketing and distribution of the UltravisionTM system across Japan. Adachi officially launched Ultravision at the The 29th Annual Meeting of the Japan Society for Endoscopic Surgery, which was held between December 8th and 10th 2016 at Yokohama, Japan.
“We are delighted to have obtained approval for the Ultravision system in Japan and entered into this comprehensive distribution partnership with Adachi Co., Ltd.” said Dominic Griffiths, Managing Director of Alesi Surgical. “Adachi has proven to be exceptionally adept at selling laparoscopic surgery products in Japan and it has a long history of success with cutting-edge technology. We look forward to a highly successful partnership.”
“Japanese physicians and hospitals have embraced cutting-edge technologies to improve patient care and healthcare economics,” said Mr. Saburo Adachi, President and CEO of Adachi Co., Ltd. “Ultravision’s unique mode of action effortlessly and unobtrusively eliminates surgical smoke particles from the operative visual field without the need for carbon dioxide exchange.”